This NCI grant, offered through its Informatics Technology for Cancer Research (ITCR) Program, invites Cooperative Agreement (U24) applications for the advanced development and enhancement of emerging informatics technologies. This grant is for improving the acquisition, management, analysis, and dissemination of data and knowledge across the entire cancer research continuum, including cancer biology, treatment, diagnosis, early detection, risk assessment, prevention, control, epidemiology, and health disparities. The focus is on technologies beyond initial prototyping, demonstrating significant broader impact, and not yet widely adopted. Proposed projects must provide a clear rationale for their necessity, detail their benefits to the cancer research field, and include mechanisms for soliciting user and collaborator feedback throughout the development process. This initiative aims to address priority needs in cancer research through technology innovation.
Opportunity ID: 338883
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CA-22-023 |
Funding Opportunity Title: | Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 24, 2022 |
Last Updated Date: | Mar 24, 2022 |
Original Closing Date for Applications: | Nov 17, 2022 |
Current Closing Date for Applications: | Nov 17, 2022 |
Archive Date: | Dec 23, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | For profit organizations other than small businesses City or township governments County governments State governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Public and State controlled institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process must be included. Potential applicants who are interested in early-stage development or informatics resource sustainment should consult the companion FOAs listed above. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-023.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00272769 | May 14, 2022 | Nov 17, 2022 | View | |
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277613 | Oct 31, 2022 | Nov 17, 2022 | View |
Package 1
Mandatory forms
338883 RR_SF424_5_0-5.0.pdf
338883 PHS398_CoverPageSupplement_5_0-5.0.pdf
338883 RR_OtherProjectInfo_1_4-1.4.pdf
338883 PerformanceSite_4_0-4.0.pdf
338883 RR_KeyPersonExpanded_4_0-4.0.pdf
338883 RR_Budget_3_0-3.0.pdf
338883 PHS398_ResearchPlan_4_0-4.0.pdf
338883 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
338883 RR_SubawardBudget30_3_0-3.0.pdf
338883 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
338883 RR_SF424_5_0-5.0.pdf
338883 PHS398_CoverPageSupplement_5_0-5.0.pdf
338883 RR_OtherProjectInfo_1_4-1.4.pdf
338883 PerformanceSite_4_0-4.0.pdf
338883 RR_KeyPersonExpanded_4_0-4.0.pdf
338883 RR_Budget_3_0-3.0.pdf
338883 PHS398_ResearchPlan_5_0-5.0.pdf
338883 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
338883 RR_SubawardBudget30_3_0-3.0.pdf
338883 PHS_AssignmentRequestForm_3_0-3.0.pdf